1. Home
  2. CELU vs BTOC Comparison

CELU vs BTOC Comparison

Compare CELU & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • BTOC
  • Stock Information
  • Founded
  • CELU 2016
  • BTOC 2020
  • Country
  • CELU United States
  • BTOC United States
  • Employees
  • CELU N/A
  • BTOC N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • BTOC
  • Sector
  • CELU Health Care
  • BTOC
  • Exchange
  • CELU Nasdaq
  • BTOC Nasdaq
  • Market Cap
  • CELU 42.2M
  • BTOC 48.3M
  • IPO Year
  • CELU N/A
  • BTOC 2024
  • Fundamental
  • Price
  • CELU $3.03
  • BTOC $1.65
  • Analyst Decision
  • CELU
  • BTOC
  • Analyst Count
  • CELU 0
  • BTOC 0
  • Target Price
  • CELU N/A
  • BTOC N/A
  • AVG Volume (30 Days)
  • CELU 491.2K
  • BTOC 22.0K
  • Earning Date
  • CELU 05-08-2025
  • BTOC 05-16-2025
  • Dividend Yield
  • CELU N/A
  • BTOC N/A
  • EPS Growth
  • CELU N/A
  • BTOC N/A
  • EPS
  • CELU N/A
  • BTOC N/A
  • Revenue
  • CELU $54,220,000.00
  • BTOC $184,757,071.00
  • Revenue This Year
  • CELU $23.29
  • BTOC $30.78
  • Revenue Next Year
  • CELU N/A
  • BTOC $17.61
  • P/E Ratio
  • CELU N/A
  • BTOC N/A
  • Revenue Growth
  • CELU 138.11
  • BTOC 8.83
  • 52 Week Low
  • CELU $1.00
  • BTOC $0.80
  • 52 Week High
  • CELU $5.22
  • BTOC $8.74
  • Technical
  • Relative Strength Index (RSI)
  • CELU 71.05
  • BTOC N/A
  • Support Level
  • CELU $2.01
  • BTOC N/A
  • Resistance Level
  • CELU $2.66
  • BTOC N/A
  • Average True Range (ATR)
  • CELU 0.24
  • BTOC 0.00
  • MACD
  • CELU 0.08
  • BTOC 0.00
  • Stochastic Oscillator
  • CELU 91.67
  • BTOC 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About BTOC Armlogi Holding Corp. Common Stock

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

Share on Social Networks: